Nature biotechnology

Keyphrases

Publications

volume 42, number 7, 2024

José Miguel Urra, Christian Gortázar, Marinela Contreras, Frederick Kabi, Paul Kasaija, Swidiq Mugerwa, Justus Rutaisire
Increasing access to biotech products for animal agriculture in Sub-Saharan Africa through partnerships. Nature biotechnology 42 (7) (2024)
Melanie Senior
Precision radiation opens a new window on cancer therapy. Nature biotechnology 42 (7) (2024)
Charlotte Harrison
CAR-Ts sweep into autoimmunity. Nature biotechnology 42 (7) (2024)
Charles Schmidt
Editor's pick: Tenpoint Therapeutics. Nature biotechnology 42 (7) (2024)
José M Muñoz, José Ángel Marinaro, José Antonio Iglesias, Moisés Sánchez, Natalia Monti, Ciro Colombara, Guido Girardi
Effects of the first successful lawsuit against a consumer neurotechnology company for violating brain data privacy. Nature biotechnology 42 (7) (2024)
Charles Schmidt
Editor's pick: Tome Biosciences. Nature biotechnology 42 (7) (2024)
Melanie Senior
Precision radiation opens a new window on cancer therapy. Nature biotechnology 42 (7) (2024)
Charles Schmidt
Editor's pick: Tenpoint Therapeutics. Nature biotechnology 42 (7) (2024)
Joachim De Jonghe, James W Opzoomer, Amaia Vilas-Zornoza, Peter Crane, Benedikt S Nilges, Marco Vicari, Hower Lee, David Lara-Astiaso, Torsten Gross, Jörg Morf, Kim Schneider, Juliana Cudini, Lorenzo Ramos-Mucci, Dylan Mooijman, Katarína Tiklová, Sergio Marco Salas, Christoffer Mattsson Langseth, Nachiket D Kashikar, Charles E S Roberts, null null, Joakim Lundeberg, Mats Nilsson, Alex K Shalek, Adam P Cribbs, Jake P Taylor-King
A community effort to track commercial single-cell and spatial 'omic technologies and business trends. Nature biotechnology 42 (7) (2024)
Iris Marchal
Counteracting tissue aging through TERT activation. Nature biotechnology 42 (7) (2024)
Iris Marchal
Vision-language AI assistance in human pathology. Nature biotechnology 42 (7) (2024)
Claire Turrell
Fungal detox: investors eye mycelium bioremediation. Nature biotechnology 42 (7) (2024)

volume 42, number 8, 2024

Martin F Pera, Andy Greene, Lon Cardon, Gregory W Carter, Elissa J Chesler, Gary A Churchill, Vivek Kumar, Cathleen Lutz, Steven Munger, Stephen A Murray, Kristen O'Connell, Laura Reinholdt, Nadia A Rosenthal
Improving the predictive power of mouse models. Nature biotechnology 42 (8) (2024)
Lukas Ehlen, Michael Schmueck-Henneresse
The rise of patient avatars in precision oncology. Nature biotechnology 42 (8) (2024)
Sean R McCutcheon, Dahlia Rohm, Nahid Iglesias, Charles A Gersbach
Epigenome editing technologies for discovery and medicine. Nature biotechnology 42 (8) (2024)
Michael Eisenstein
Biotechs take multiplexing into animal models to accelerate drug discovery. Nature biotechnology 42 (8) (2024)
Lukas Ehlen, Michael Schmueck-Henneresse
The rise of patient avatars in precision oncology. Nature biotechnology 42 (8) (2024)
Iris Marchal
Joint profiling of drug-chromatin binding and epigenetic landscapes in single cells. Nature biotechnology 42 (8) (2024)
Michael Eisenstein
Editor's pick: Empress Therapeutics. Nature biotechnology 42 (8) (2024)
Michael Eisenstein
Editor's pick: Unnatural Products. Nature biotechnology 42 (8) (2024)
Iris Marchal
A base editor modifies bacterial genes in the guts of living mice. Nature biotechnology 42 (8) (2024)
Sean R McCutcheon, Dahlia Rohm, Nahid Iglesias, Charles A Gersbach
Epigenome editing technologies for discovery and medicine. Nature biotechnology 42 (8) (2024)
Iris Marchal
Editor's pick: Indapta Therapeutics. Nature biotechnology 42 (8) (2024)
Iris Marchal
A base editor modifies bacterial genes in the guts of living mice. Nature biotechnology 42 (8) (2024)
Monica Hoyos Flight
Spanish tortillas go vegan. Nature biotechnology 42 (8) (2024)
Mabel Andalón, Catherine de Fontenay, Donna K Ginther, Kwanghui Lim
The rise of teamwork and career prospects in academic science. Nature biotechnology 42 (8) (2024)
Andrew W Torrance, de la Fuente-Nunez Cesar
The patentability and bioethics of molecular de-extinction. Nature biotechnology 42 (8) (2024)
Cormac Sheridan
A new class of mRNA drugs targets poison exons. Nature biotechnology 42 (8) (2024)
Iris Marchal
Bridge RNAs direct programmable DNA rearrangements. Nature biotechnology 42 (8) (2024)
Martin F Pera, Andy Greene, Lon Cardon, Gregory W Carter, Elissa J Chesler, Gary A Churchill, Vivek Kumar, Cathleen Lutz, Steven Munger, Stephen A Murray, Kristen O'Connell, Laura Reinholdt, Nadia A Rosenthal
Improving the predictive power of mouse models. Nature biotechnology 42 (8) (2024)
Cormac Sheridan
A new class of mRNA drugs targets poison exons. Nature biotechnology 42 (8) (2024)
Monica Hoyos Flight
Spanish tortillas go vegan. Nature biotechnology 42 (8) (2024)
Iris Marchal
Joint profiling of drug-chromatin binding and epigenetic landscapes in single cells. Nature biotechnology 42 (8) (2024)
Andrew W Torrance, de la Fuente-Nunez Cesar
The patentability and bioethics of molecular de-extinction. Nature biotechnology 42 (8) (2024)
Michael Eisenstein
Editor's pick: Unnatural Products. Nature biotechnology 42 (8) (2024)
Iris Marchal
Editor's pick: Indapta Therapeutics. Nature biotechnology 42 (8) (2024)
Iris Marchal
Bridge RNAs direct programmable DNA rearrangements. Nature biotechnology 42 (8) (2024)
Michael Eisenstein
Editor's pick: Empress Therapeutics. Nature biotechnology 42 (8) (2024)
Michael Eisenstein
Biotechs take multiplexing into animal models to accelerate drug discovery. Nature biotechnology 42 (8) (2024)
Mabel Andalón, Catherine de Fontenay, Donna K Ginther, Kwanghui Lim
The rise of teamwork and career prospects in academic science. Nature biotechnology 42 (8) (2024)

volume 42, number 9, 2024

Lauren A Patel, Yuwei Cao, Eric M Mendenhall, Christopher Benner, Alon Goren
The Wild West of spike-in normalization. Nature biotechnology 42 (9) (2024)
Kara M Donovan, Robert S Goldsmith, Erica V Ely, Samridhi Garg, Lloyd P Ruiz, Mitre Athaiya, Sophia Meyer, Michelle Sydney Smith, Ishtiaq Mawla
A virtual case competition approach to bridging business acumen and biomedical graduate training. Nature biotechnology 42 (9) (2024)
Iris Marchal
Targeting fatty acid metabolism promotes a healthy vaginal microbiome. Nature biotechnology 42 (9) (2024)
Michael Francisco
1H24 biotech job picture. Nature biotechnology 42 (9) (2024)
Michael Eisenstein
Foundation models build on ChatGPT tech to learn the fundamental language of biology. Nature biotechnology 42 (9) (2024)
Iris Marchal
Engineered parasite delivers therapeutic proteins to the mouse brain. Nature biotechnology 42 (9) (2024)
Daniel Grushkin
Biogenetic Blooms: it's microbial, and it's art. Nature biotechnology 42 (9) (2024)
Iris Marchal
Intestinal organoids with an autologous immune compartment. Nature biotechnology 42 (9) (2024)
Mark Peplow
Enzymes boost 'rock weathering' to trap CO 2 in soil. Nature biotechnology 42 (9) (2024)
Jonathan J Darrow, Victor Van de Wiele, Beatrice Brown, Aaron S Kesselheim
The prevalence of post-NDA drug patents and their relationship to the timing of generic approval. Nature biotechnology 42 (9) (2024)